Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Clinical trial NCT01705990 · COMPLETED
Trial details
- NCT number
- NCT01705990
- Sponsor
- International AIDS Vaccine Initiative
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2015-03-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.